Holding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...

Some valuation ratios are used because they are easy. The PE ratio is one of them. It is simple, familiar, and convenient. Not only for the...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

CPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...

RIL is set to invest ₹1.6 lakh cr (over $17 bn) to develop a 1.5 GW AI-focused data centre cluster along with a captive solar and battery s...

India and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...

India aims for $2 trillion in exports by 2030. Current growth is slow, and global market share is small. The country faces challenges in ex...

India's pharmaceutical industry total market size is projected to reach $130 billion by 2030 and an impressive $450 billion by 2047, highli...

Alongside the exhibition, the Global Regulatory Conclave, held with CDSCO and Pharmexcil, spotlights reliance practices, pharmacopoeia conv...

Drugmakers in India may soon face stricter enforcement of quality standards. The revised Schedule M, which details manufacturing practices ...

Two entities -- Lakumi Trust and Nicomac Machinery -- on Tuesday divested a 4.9 per cent stake in Gland Pharma for Rs 1,411 crore through o...

Nicomac Machinery and RP Advisory Services are looking at raising Rs 1,400 crore through the sale, and have set the floor price for the sam...

The top 25 pharma brands by size have a total active job openings count of about 4,500 jobs globally and only 6% of these active openings a...

Major pharmaceutical firms have sought more time as they have not been able to obtain the necessary regulatory approvals in time.

To bring vibrancy in the Gujarat’s pharma machinery sector; the government is ready to provide impetus by developing specialized engineerin...

Levy of excise duty @10% (plus 3% cess) on the inputs (active pharmaceutical ingredients or API) whereas the output is taxed @4% (plus 3% c...

The pharmaceutical industry in Gujarat has undoubtedly created ripples and very definitely has a bright future ahead.